avantiavanti

Forumberichten

1. Forum dec '21

   Galapagos december 2021

   Door: avantiavanti Forum: Galapagos

   Kempen 6 december 2021Optionality too large to ignoreGoing into the new year, Galapagos stock is in a holding patternawaiting a catalyst to unlock the negative EV value. Given limitednear-term pipeline newsflow and a ...

2. Forum dec '21

   Analyst reports 2021

   Door: avantiavanti Forum: Galapagos

   Kempen 6 december 2021[b]Optionality too large to ignore[/bGoing into the new year, Galapagos stock is in a holding patternawaiting a catalyst to unlock the negative EV value. Given limitednear-term pipeline newsflow ...

3. Forum jul '21

   Galapagos juli 2021

   Door: avantiavanti Forum: Galapagos

   Op de analyst draad staan nog een paar andere updates.Morgan StanleyToledo Demonstrates POC, But Next Compound Needed For Higher Doses; TYK2 AdvancingStock Rating OverweightPrice Target $118.00Matthew Harrison, Connor...

4. Forum jun '21

   Galapagos juni 2021

   Door: avantiavanti Forum: Galapagos

   Ik heb destijds een bericht gestuurd naar Galapagos over waar de 150 miljoen opt in precies betrekking op had. Kan het antwoord niet meer terugvinden, maar herinner mij dat de bewoording per compound was en dat een co...

5. Forum apr '21

   Galapagos April 2021

   Door: avantiavanti Forum: Galapagos

   Morgan Stanley samenvatting. Hoop later op de dag full report te plaatsen op analyst draad. Bristols TYK2 Safety Is a Positive for GLPG3667Stock Rating OverweightPrice Target $117.00Matthew Harrison, Connor Meehan...

6. Forum apr '21

   Inhoudelijk Toledo Draadje

   Door: avantiavanti Forum: Galapagos

   Rigorous new review of SIKs biology and therapeutic potential for diseaseses.Nuts and bolts of the salt-inducible kinases (SIKs)

7. Forum dec '20

   inhoudelijk LIGHT

   Door: avantiavanti Forum: Galapagos

   quote:BigMoepf schreef op 17 december 2020 16:51:[...Achteraf gezien hadden ze misschien beter alleen de 200mg aangevraagd. Dan had de FDA alvast geen mening over de dosages moeten geven.Eens. En daar bovenop nu de si...

8. Forum dec '20

   Analyst reports 2020

   Door: avantiavanti Forum: Galapagos

   Degroof Petercam 16 december (na webast)HoldPT €90Downside risk materially reduced, but patience prevails

9. Forum okt '20

   GLPG1205 en GLPG1690

   Door: avantiavanti Forum: Galapagos

   Morgan Stanley extract update 26 oktober 2020Stock Rating Equal-weightPrice Target $159.00Matthew Harrison, Connor Meehan, Zhen Zeng, Ph.D.Catalyst Driven Idea: PhII IPF Data From PINTA StudyPhII data for GLPG1205 in ...

10. Forum okt '20

    GLPG0634 (Filgotinib)

    Door: avantiavanti Forum: Galapagos

    Galapagos NV (GLPG.O)Catalyst Driven Idea: US Filgotinib OutcomesNorth AmericaStock Rating Equal-weightPrice Target $159.00Matthew Harrison, Connor Meehan, Thomas F Lavery, J.D.October 19, 2020A potential decision...

11. Forum okt '20

    Galapagos oktober 2020

    Door: avantiavanti Forum: Galapagos

    Dank voor jullie updates nav Bolero Biotechevent!

12. Forum sep '20

    15-6-2020: Galapagos is een BUY

    Door: avantiavanti Forum: Galapagos

    Ter aanvulling nog een keer het relaas van Dr Jon Goldhill nav Eular 2020.EULAR 2020: New data presented from the FINCH program including 52wk results and an integrated safety analysis

13. Forum aug '20

    Galapagos september 2020

    Door: avantiavanti Forum: Galapagos

    Mooie opening Kelewan. Succes iedereen

14. Forum jun '20

    Galapagos juni 2020

    Door: avantiavanti Forum: Galapagos

    Analyse van 52 weeks data op Eular door Dr Jon Goldhill

15. Forum apr '20

    Galapagos april 2020

    Door: avantiavanti Forum: Galapagos

    quote:Ikkedike schreef op 25 april 2020 07:06:Ook minder grote spelers melden impact. Galapagos stopt vijf onderzoeken. Dat besluit zal de ontwikkeling van het auto-immuunmedicijn FIlgotinib - een potentile ‘billion d...

16. Forum feb '20

    Galapagos februari 2020

    Door: avantiavanti Forum: Galapagos

    BEIJING – China will kickstart a phase III trial Feb. 3 to determine whether patients with 2019-nCoV can be treated with Gilead Sciences Inc.’s NUC inhibitor, remdesivir, which was originally developed for Ebola, four...

17. Forum jan '20

    Galapagos januari 2020

    Door: avantiavanti Forum: Galapagos

    Gilead Against Coronavirus seekingalpha.com/article/4319400-gile...

18. Forum jan '20

    Analyst reports 2019

    Door: avantiavanti Forum: Galapagos

    [b]Barclays 20 januari 2020 Galapagos (OW, PT €225; FY19 – 20th February, AMC)Thoughts on the quarter/expectations: Whilst we got a lot of incoming questionsregarding GLPG’s strong performance in 4Q19, we saw a number...

19. Forum dec '19

    Overzicht (kandidaat)medicijnen

    Door: avantiavanti Forum: Galapagos

    Thanks Pokerface! En goede suggestie van WiC32 in post hierboven.

20. Forum nov '19

    Galapagos november 2019

    Door: avantiavanti Forum: Galapagos

    seekingalpha.com/article/4308467-gala...

21. Forum okt '19

    Galapagos oktober 2019

    Door: avantiavanti Forum: Galapagos

    Hi WST thanks for copying and sharing extracts from analyst reports. Please include pdf of source that I post on analyst thread so it stays in context and keeps me/us out of trouble.

22. Forum sep '19

    Duiding Voorstellen AVA 22-10-2019

    Door: avantiavanti Forum: Galapagos

    Dank voor de genomen moeite FluitendeVogels!

23. Forum aug '19

    Galapagos augustus 2019

    Door: avantiavanti Forum: Galapagos

    Uit Barclays update van gisteren (staat op analyst draad):Whilst GLPG shares have given back some of their post-deal gains, shares remain +20% vs. SXDP +6%. We suspect that some of the post-deal movement in the shares...

24. Forum jul '19

    Galapagos juli 2019

    Door: avantiavanti Forum: Galapagos

    Citi verhoogt vandaag pt van 115 euro naar 140 euro. Rapport op analyst draad.

25. Forum jun '19

    GLPG1972

    Door: avantiavanti Forum: Galapagos

    H.C.WainwrightCO 12 juni 2019ROCELLA Is Off to a Running Start; GLPG1972 Recap